Tango Therapeutics, Inc.
NASDAQTango Therapeutics heads into its May 15 earnings print having already moved the market — the question now is whether the fundamental story has caught up with the repositioning. The most striking shift in positioning is on the short side. At 25.7% of the free float, short interest remains high in absolute terms, but the directional move is dramatic: shorts have cut exposure by more…
Snapshot as of 15 May 2026
Tango Therapeutics heads into its May 15 earnings print having already moved the market — the question now is whether the fundamental story has caught up with the repositioning. The most striking shift in positioning…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TNGX — free to start on ORTEX.
Sign up for free →Open TNGX on ORTEX